Mild Caloric Restriction Decreases Insulin Requirements in Patients With Type 2 Diabetes and Severe Insulin Resistance
- PMID: 26222846
- PMCID: PMC4554137
- DOI: 10.1097/MD.0000000000001160
Mild Caloric Restriction Decreases Insulin Requirements in Patients With Type 2 Diabetes and Severe Insulin Resistance
Abstract
Type 2 diabetes (T2D) affects ~10% of the US population, a subset of whom have severe insulin resistance (SIR) (>200 units/d). Treatment of these patients with high-dose insulin presents logistical and compliance challenges. We hypothesized that mild caloric restriction would reduce insulin requirements in patients with T2D and SIR.This was a retrospective study at the National Institutes of Health Clinical Center. Inclusion criteria were as follows: T2D, and insulin dose >200 units/d or >2 units/kg/d. The intervention consisted of mild caloric restriction during a 3 to 6-day hospitalization. The major outcomes were change in insulin dose and blood glucose from admission to discharge.Ten patients met inclusion criteria. Baseline glycated hemoglobin A1c was 10.0 ± 1.6% and body mass index 38.8 ± 9.0 kg/m. Food intake was restricted from 2210 ± 371 kcal/d preadmission to 1810 ± 202 during the hospital stay (16.5% reduction). Insulin dose decreased from 486 ± 291 units/d preadmission to 223 ± 127 at discharge (44% reduction, P = 0.0025). Blood sugars decreased nonsignificantly in the fasting state (from 184 ± 85 to 141 ± 42, P = 0.20), before lunch (239 ± 68 to 180 ± 76, P = 0.057), and at bedtime (212 ± 95 to 176 ± 48, P = 0.19), and significantly decreased before dinner (222 ± 92 to 162 ± 70, P = 0.016).Mild caloric restriction, an accessible and affordable intervention, substantially reduced insulin doses in patients with T2D and SIR. Further studies are needed to determine if the intervention and results are sustainable outside of a hospital setting.
Conflict of interest statement
There was no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Figures



References
-
- Bauman WA, Schwartz E, Rose HG, et al. Early and long-term effects of acute caloric deprivation in obese diabetic patients. Am J Med 1988; 85:38–46. - PubMed
-
- Cochran E, Musso C, Gorden P. The use of U-500 in patients with extreme insulin resistance. Diabetes Care 2005; 28:1240–1244. - PubMed
-
- Cochran EK, Valentine V, Samaan KH, et al. Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key. Diabetes Educ 2014; 40:153–165. - PubMed
-
- Distiller LA, Nortje H, Wellmann H, et al. Treatment of the obese type 2 diabetes patient with severe insulin resistance: a 24-week, prospective, randomized, ppen-label, treat-to-target study: a pilot study to compare the efficacy of U-500 regular insulin plus metformin with U-500 regular insulin, metformin, and exenatide. Endocr Pract 2014; 1–26. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous